Guenther Koehne clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   CD34+ Transplants for Myeloid Malignancies

   Primary and study completion pushed from Jun 2033 to Jan 2034

   Also in this update: Primary endpoint(s) modified; Enrollment reduced: 100 → 50 participants

   Guenther Koehne·Phase 2· NCT05565105· Registry history of NCT05565105 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

2. Notable

   CD34+ Enriched Transplants · Myelodysplastic Syndrome

   Trial status changed: Suspended → Not Yet Recruiting

   Guenther Koehne·Not applicable· NCT05617625· Registry history of NCT05617625 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.